Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury

Receptor for advanced-glycation end products (RAGE) and its ligands AGEs and S100/calgranulins have been implicated in a range of disorders. However, the role of RAGE/ligand interaction in neointimal hyperplasia after vascular injury remains unclear. We examined the expression of RAGE and its ligand...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 2003-05, Vol.107 (17), p.2238-2243
Hauptverfasser:	ZHONGMIN ZHOU, KAI WANG, SCHMIDT, Ann Marie, LINCOFF, A. Michael, TOPOL, Eric J, PENN, Marc S, MARSO, Steven P, LAUER, Michael A, FORUDI, Farhad, XIAORONG ZHOU, WU QU, YAN LU, STERN, David M
Format:	Artikel
Sprache:	eng
Schlagworte:	Angioplasty, Balloon - adverse effects Animals Arterial Occlusive Diseases - blood Arterial Occlusive Diseases - etiology Arterial Occlusive Diseases - pathology Biological and medical sciences Blood Glucose - analysis Cell Division - drug effects Cells, Cultured Diseases of the cardiovascular system Glycation End Products, Advanced - analysis Glycation End Products, Advanced - immunology Immunohistochemistry Kinetics Leukocyte L1 Antigen Complex - analysis Leukocyte L1 Antigen Complex - immunology Ligands Lipids - blood Medical sciences Muscle, Smooth, Vascular - drug effects Muscle, Smooth, Vascular - pathology Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Rats Rats, Zucker Receptor for Advanced Glycation End Products Receptors, Immunologic - analysis Receptors, Immunologic - immunology Receptors, Immunologic - physiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!